Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

1,250.00p
   
  • Change Today:
      60.00p
  • 52 Week High: 1,430.00
  • 52 Week Low: 367.50
  • Currency: UK Pounds
  • Shares Issued: 48.75m
  • Volume: 60,651
  • Market Cap: £609.42m
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
67.31% above the market average67.31% above the market average67.31% above the market average67.31% above the market average67.31% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
1yr Revenue Growth
69.61% above the market average69.61% above the market average69.61% above the market average69.61% above the market average69.61% above the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
17.59% above the market average17.59% above the market average17.59% above the market average17.59% above the market average17.59% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Price Book Ratio
84.75% below the market average84.75% below the market average84.75% below the market average84.75% below the market average84.75% below the market average
58.33% below the sector average58.33% below the sector average58.33% below the sector average58.33% below the sector average58.33% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
63.67% above the market average63.67% above the market average63.67% above the market average63.67% above the market average63.67% above the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average
Price Chg 3m
12.84% above the market average12.84% above the market average12.84% above the market average12.84% above the market average12.84% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
30.26% above the market average30.26% above the market average30.26% above the market average30.26% above the market average30.26% above the market average
38.18% above the sector average38.18% above the sector average38.18% above the sector average38.18% above the sector average38.18% above the sector average
Momentum 20
96.81% above the market average96.81% above the market average96.81% above the market average96.81% above the market average96.81% above the market average
96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
38.32% above the market average38.32% above the market average38.32% above the market average38.32% above the market average38.32% above the market average
65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average65.71% above the sector average
ROCE
73.89% above the market average73.89% above the market average73.89% above the market average73.89% above the market average73.89% above the market average
47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average47.37% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
69.54% above the market average69.54% above the market average69.54% above the market average69.54% above the market average69.54% above the market average
76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average76.00% above the sector average
Forecast EPS
34.55% above the market average34.55% above the market average34.55% above the market average34.55% above the market average34.55% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
25.97% above the market average25.97% above the market average25.97% above the market average25.97% above the market average25.97% above the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average
Operating Profit Loss
51.12% above the market average51.12% above the market average51.12% above the market average51.12% above the market average51.12% above the market average
73.08% above the sector average73.08% above the sector average73.08% above the sector average73.08% above the sector average73.08% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
20.33% above the market average20.33% above the market average20.33% above the market average20.33% above the market average20.33% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Cash
22.30% above the market average22.30% above the market average22.30% above the market average22.30% above the market average22.30% above the market average
34.62% above the sector average34.62% above the sector average34.62% above the sector average34.62% above the sector average34.62% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
39.35% above the market average39.35% above the market average39.35% above the market average39.35% above the market average39.35% above the market average
3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 1,250.00p
Change Today 60.00p
% Change 5.04 %
52 Week High 1,430.00
52 Week Low 367.50
Volume 60,651
Shares Issued 48.75m
Market Cap £609.42m
Beta 0.01

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.69% below the market average96.69% below the market average96.69% below the market average96.69% below the market average96.69% below the market average
96.15% below the sector average96.15% below the sector average96.15% below the sector average96.15% below the sector average96.15% below the sector average
Price Trend
91.40% above the market average91.40% above the market average91.40% above the market average91.40% above the market average91.40% above the market average
85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average85.96% above the sector average
Income Not Available
Growth
92.74% above the market average92.74% above the market average92.74% above the market average92.74% above the market average92.74% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 14-May-2021

Time Volume / Share Price
16:35 1,106 @ 1,250.00p
16:29 105 @ 1,250.00p
16:29 12 @ 1,250.00p
16:29 143 @ 1,250.00p
16:29 96 @ 1,237.50p

Ergomed Key Personnel

CFO Richard Barfield
COO Lewis Cameron

Top of Page